Patents by Inventor Heather Gordon

Heather Gordon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treating amyloidosis
    Publication number: 20110281951
    Abstract: Therapeutic compounds and methods for modulating amyloid aggregation in a subject, whatever its clinical setting, are described. Amyloid aggregation is modulated by the administration to a subject of an effective amount of a therapeutic compound of the formula or a pharmaceutically acceptable salt or ester, such that modulation of amyloid aggregation occurs. R1 and R2 are each independently a hydrogen atom or a substituted or unsubstituted aliphatic or aryl group. Z and Q are each independently a carbonyl (C?O), thiocarbonyl (C?S), sulfonyl (SO2), or sulfoxide (S?O) group. “k” and “m” are 0 or 1, provided when k is 1, R1 is not a hydrogen atom, and when m is 1, R2 is not a hydrogen atom. In an embodiment, at least one of k or m must equal 1. “p” and “s” are each independently positive integers selected such that the biodistribution of the therapeutic compound for an intended target site is not prevented while maintaining activity of the therapeutic compound.
    Type: Application
    Filed: April 14, 2011
    Publication date: November 17, 2011
    Inventors: Walter Szarek, Donald Weaver, Xianqi Kong, Heather Gordon
  • Compositions and methods for treating amyloidosis
    Publication number: 20090099100
    Abstract: Therapeutic compounds and methods for modulating amyloid aggregation in a subject, whatever its clinical setting, are described. Amyloid aggregation is modulated by the administration to a subject of an effective amount of a therapeutic compound of the formula or a pharmaceutically acceptable salt or ester, such that modulation of amyloid aggregation occurs. R1 and R2 are each independently a hydrogen atom or a substituted or unsubstituted aliphatic or aryl group. Z and Q are each independently a carbonyl (C?O), thiocarbonyl (C?S), sulfonyl (SO2), or sulfoxide (S?O) group. “k” and “m” are 0 or 1, provided when k is 1, R1 is not a hydrogen atom, and when m is 1, R2 is not a hydrogen atom. In an embodiment, at least one of k or m must equal 1. “p” and “s” are each independently positive integers selected such that the biodistribution of the therapeutic compound for an intended target site is not prevented while maintaining activity of the therapeutic compound.
    Type: Application
    Filed: July 7, 2008
    Publication date: April 16, 2009
    Applicant: Bellus Health (International) Limited
    Inventors: Walter Szarek, Donald Weaver, Xianqi Kong, Heather Gordon
  • PERFORATOR WITH INNER AND OUTER DRILLS AND A DRIVE HEAD, THE INNER DRILL CONFIGURED TO MOVE AGAINST THE OUTER DRILL IN ORDER TO DISENGAGE FROM THE DRIVE HEAD
    Publication number: 20090024129
    Abstract: A cranial perforator with an inner drill and an outer drill that surrounds the inner drill. Both drills are rotated by a head. Once the inner drill penetrates the bone, the inner drill moves against the outer drill. This movement causes the inner drill to disengage from the perforator head. The disengagement of the inner drill from the perforator head serves to stop the rotation of both drills.
    Type: Application
    Filed: July 19, 2007
    Publication date: January 22, 2009
    Inventors: Jeremy Gordon, Kevin Manley, Heather Gordon
  • Compositions and methods for treating amyloidosis
    Publication number: 20040198832
    Abstract: Therapeutic compounds and methods for modulating amyloid aggregation in a subject, whatever its clinical setting, are described.
    Type: Application
    Filed: August 11, 2003
    Publication date: October 7, 2004
    Applicants: Queen's University at Kingston, Neurochem (International) Limited
    Inventors: Walter A. Szarek, Donald F. Weaver, Xianqi Kong, Heather Gordon